Small molecule compositions for sexual dysfunction

Details Small molecule compositions for sexual dysfunction Small molecule compositions for sexual dysfunction

2005-01-14

2009-06-23

Wilson, James O (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S393000

Reexamination Certificate

active

07550602

ABSTRACT:
Compounds of the general formula:or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, and X are as defined. Further provided are methods for treatment of sexual dysfunction, including erectile dysfunction and female sexual dysfunction, and combination drugs and method of use thereof, including a compound of the invention and one or more second sexual dysfunction pharmaceutical agents.

REFERENCES:
patent: 6350760 (2002-02-01), Bakshi et al.
patent: 6376509 (2002-04-01), Bakshi et al.
patent: 6410548 (2002-06-01), Nargund et al.
patent: 6458790 (2002-10-01), Palucki et al.
patent: 6472398 (2002-10-01), Palucki et al.
patent: 6534503 (2003-03-01), Dines et al.
patent: 6579968 (2003-06-01), Blood et al.
patent: 2002/0004512 (2002-01-01), Bakshi et al.
patent: 2002/0137664 (2002-09-01), Bakshi et al.
patent: 2002/0143141 (2002-10-01), Chen et al.
patent: 2003/0069169 (2003-04-01), Macor et al.
patent: 2003/0083228 (2003-05-01), Carpino et al.
patent: 2004/0192676 (2004-09-01), Chen
patent: 2004/0254198 (2004-12-01), Reynolds et al.
patent: 2004/0266821 (2004-12-01), Ujjainwalla et al.
patent: 2005/0075344 (2005-04-01), Backer et al.
patent: 2005/0176728 (2005-08-01), Sharma et al.
patent: 2005/0272718 (2005-12-01), Ammenn et al.
patent: WO 02/18437 (2002-03-01), None
patent: WO 02/064091 (2002-08-01), None
patent: WO 03/006620 (2003-01-01), None
Van der Ploeg, et al. A role for the melanocortin 4 receptor in sexual function.Proc Natl Acad Sci USA99:11381-6 (2002).
Vergoni, et al. Chronic melanocortin 4 receptor blockage causes obesity without influencing sexual behavior in male rats.J Endocrino, 166:419-26 (2000).
Synthetic Peptides: A User's Guide, GA Grant, editor, W.H. Freeman & Co., New York, 1992, the teachings of which are incorporated herein by reference, including the text and table set forth at pp. 11 through 24.
Hruby VJ, Al-obeidi F and Kazmierski W:Biochem J268:249-262, 1990.
Toniolo C:Int J Peptide Protein Res35:287-300, 1990.
M.E. Hadley et al., Discovery and development of the novel melanogenic drugs, inIntegration of Pharmaceutical Discovery and Development: Case Studies, edited by Borschart et al., Plenum Press, New York (1998).
R.T. Dorr et al., Evaluation of Melanotan-II, A Superpotent Cyclic Melanotropic Peptide in a Pilot Phase-I Clinical Study.Life Sci.58:1777-1784 (1996).
R.A.H. Adan, Identification of Antagonists for Melanocortin MC3, MC4, and MC5 Receptors.Eur. J. Pharmacol., 269:331-337 (1994).

Affiliated with

Also associated with

Rating

Small molecule compositions for sexual dysfunction does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Small molecule compositions for sexual dysfunction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Small molecule compositions for sexual dysfunction will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4146097